Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are the second most common cause of autosomal-dominant Parkinson’s disease (PD), and increased LRRK2 kinase activity is also observed in idiopathic PD, making LRRK2 a major actionable therapeutic target. LRRK2 is a 286-kDa multidomain enzyme containing a Ras-like GTPase...
Amalia Villagran Suarez, Kathryn S. Hatch, Tatyana Bodrug et al.· bioRxiv· 1 citation
It is shown that PRF functions as a regulatory signal that rewires host translation in favor of viral replication, highlighting PRF as a stress-inducing module that enhances viral replication.
Audrey Xavier, Melinda Kolling, Ashley M. Bourke et al.· Cell· 0 citations
A unified framework for understanding LRRK2 regulation with broad therapeutic implications is provided, showing that the ROC GTPase governs switching between autoinhibited and active states: GTP binding promotes activation, whereas GDP binding enforces autoinhibition.
Amalia Villagran Suarez, Kathryn S. Hatch, Tatyana Bodrug et al.· Cell· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.